Lawmaker calls for P2-B fund for Dengvaxia recipients

A LAWMAKER is calling on the French pharmaceutical giant Sanofi Pasteurto put up an escrow fund of at least P2 billion for the hospitalizations needs of schoolchildren who received the anti-dengue vaccine.

In a statement, Negros Oriental refund of P1.2 billion for unused vaccines is “not enough for the the severe damage millions of Filipinos face as a result of the anti-dengue drug.”

“There is no telling when an individual who was misled into getting Dengvaxia shots will have severe dengue. A number of cases of deaths and serious ailments have been recorded as a result of the ineffective vaccine,” Teves said.

be voluntarily to show Filipinos that it is ready to help prevent the dengue threat.

“Such act should not be mis measure that would settle its crimi- nal and civil liability to Dengvaxia

Teves also called on the Depart charges against former and incum in the program’s implementation.

About 800,000 schoolchildren received the anti-dengue vaccine as part of a program seeking to minimize dengue, which the Aquino administration initiated in 2016.

The implementation of the project was cancelled late last year after vaccine was only safe and effective for people who had been infected with dengue before vaccination.

However, if taken by those who were not affected by the virus, it may cause severe dengue.

Forensic Laboratory Director Erwin those whose deaths were believed to have been caused by the Dengvaxia vaccine were extensive organ bleeding and enlarged organs.